Susquehanna International Group
CPIX icon

Susquehanna International Group’s Cumberland Pharmaceuticals CPIX Stock Holding History

Susquehanna International Group’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54.6K Buy
16,800
+2,800
+20% +$10.8K ﹤0.01% 12616
2025
Q4 		$55.7K Buy
+14,000
New +$41.5K ﹤0.01% 11715

Other funds holding CPIX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Susquehanna International Group's CPIX Position: Q1 2026 in Review

Susquehanna International Group sold out of Cumberland Pharmaceuticals (CPIX) in Q1 2026, closing a stake of 26,038 shares — an estimated $100K sold.

Susquehanna International Group first reported a position in CPIX in Q1 2023 and held it in 5 quarters. The position peaked at $122K in Q1 2025. 29 funds tracked by Wall St. Rank hold CPIX as of Q1 2026.

  • Susquehanna International Group reported no remaining Cumberland Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 26,038 Cumberland Pharmaceuticals shares in Q1 2026, an estimated $100K.
  • Susquehanna International Group first reported a position in Cumberland Pharmaceuticals in Q1 2023 and held it in 5 quarters.
  • Susquehanna International Group's Cumberland Pharmaceuticals position peaked at $122K in Q1 2025.
  • 29 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.